Montreal InVivo is partnering with Canadian Clinical Trails Coordinating Centre(CCTCC) to enhance Canada's clinical research capabilities

Wednesday, June 8, 2016 Clinical Trials News J E 4

OTTAWA, June 7, 2016 /CNW/ - Canada - Canadian Clinical Trials Coordinating Centre (CCTCC) and Montreal InVivo 

The partnership between Montreal InVivo and the Canadian Clinical Trials Coordinating Centre (CCTCC) will result in the addition of Quebec clinical trial investigators' data from Montreal Goes Clinic to the Canadian ClinicalTrials Asset Map (CCTAM) and real-time updates down the line. For a preview, visit:

''This portal is not only a great opportunity for visibility for Quebec's researchers and investigators throughout Canada, but will also showcase the province's capabilities in clinical research'' said Frank Béraud, CEO of Montréal InVivo. The CCTAM database is designed to promote Canada as a leading competitive nation for clinical trials by providing a comprehensive picture of the breadth and depth of Canada's clinical research assets.

"The CCTAM has quickly established itself as a useful tool for enhancing Canada's competitiveness for clinical research," said Dr. Shurjeel Choudhri, Senior Vice President and Head, Medical and Scientific Affairs Bayer Inc. and the current Chair of the CCTCC Executive Committee.  "The CCTAM is a great example of the collaboration of multiple stakeholders from across Canada, including representatives from the Federal and Provincial governments, industry, the Canadian Institutes of Health Research and HealthCareCAN. The addition of clinical investigator data from Montreal Goes Clinic is an important step in the CCTAM becoming a truly comprehensive inventory of Canada's clinical research assets."


  • Clinical trials help develop new, potentially life-saving medications, vaccines and therapies, in addition to supporting Canada's knowledge-based economy.
  • Montreal Goes Clinic relies on the active collaboration of several public and private multidisciplinary partners that have a wealth of expertise and experience in clinical studies. More than 500 investigator assets will be added to CCTAM database.
  • In addition to being the North American leader in early phase clinical trials per capita, Greater Montreal has five main areas of expertise in clinical research: neurosciences, oncology, cardio-metabolic diseases, mother-child research and infectious diseases.
  • The CCTAM is one of the key projects of the of Canadian Clinical Trials Coordinating Centre (CCTCC); an unique collaborative initiative funded by industry represented by Innovative Medicines Canada, government represented by the Canadian Institutes of Health Research (CIHR) and healthcare institutions represented by HealthCareCAN. The CCTAM was launched on June 4, 2015 by SenatorKelvin K. Ogilvie and currently has over 1000 clinical research assets.
  • The CCTAM offers tremendous marketing benefits to clinical research organizations and investigators as it is available to clinical trial sponsors in Canada and internationally. It showcases the existing talents and expertise at Canadian research institutions and their ability to conduct cutting edge clinical trials. It benefits clinical trial sponsors as it allows placing trials effectively and efficiently reducing clinical trial start-up times.


About Montreal Goes Clinic

Montreal Goes Clinic is an initiative by Greater Montreal's life sciences' cluster that aims to make the region a world-class centre of expertise in early stage clinical trials.  The initiative will improve Greater Montreal's business environment to help pharmaceuticals, biotechs, contract research organizations (CRO's) and medical device companies perform high quality clinical trials and run clinical proofs-of-concept, thus  increasing patient access to new treatments and improving medical practices by allowing clinicians to work with technologies of tomorrow and the best equipment.

About the Canadian Clinical Trials Coordinating Centre (CCTCC)

The CCTCC, established in 2014, is a unique collaboration between industry, government and healthcare institutions. Key objectives are to improve the operational environment for clinical trials in Canada and promote it as a destination of choice for clinical trials.

About the Canadian Clinical Trials Asset Map (CCTAM)

The Canadian Clinical Trials Asset Map (CCTAM) is a unique, robust, searchable web-based database designed to showcase Canada's clinical research strengths. It is the first pan-Canadian research inventory with an integrated map-based search function that lists Canadian investigators, clinical research sites, hospitals, institutions, research ethics boards, CRO's, site management organizations (SMOs), and other clinical research resources available across the country.


SOURCE Canadian Clinical Trials Coordinating Centre (CCTCC)



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The Prostate Cancer Market 2016-2026: Increasing I...
Menstrual Cups Global Market Professional Survey R...